11-Dehydrothromboxane B2
| Names | |
|---|---|
| IUPAC name
(5Z,9S,13E,15S)-9,15-Dihydroxy-11-oxothromboxa-5,13-dien-1-oic acid
| |
| Systematic IUPAC name
(5Z)-7-{(2R,3S,4S)-4-Hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-6-oxooxan-3-yl}hept-5-enoic acid | |
| Other names
11-Dehydro-thromboxane B2
| |
| Identifiers | |
3D model (JSmol)
|
|
| ChEBI | |
| ChemSpider | |
| KEGG | |
PubChem CID
|
|
| UNII | |
| |
| |
| Properties | |
| C20H32O6 | |
| Molar mass | 368.46 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
| |
11-Dehydrothromboxane B2 (or 11-dehydro-TXB2) is produced from the breakdown of thromboxane A2. It is released by activated platelets and urine levels of 11-dehydro-TXB2 can be used to monitor the response to aspirin therapy when used to prevent heart disease and in diseases where platelet activation is prominent.